Full name
MED - PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
58.14.Z - Publishing activities
78.10.Z - Employment placement and recruitment services
78.30.Z - Employment activities
86.90.E - Healthcare
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -13,3 | -10,7 | -7,1 | 34,2 |
EBITDA | -12 | -8,8 | -4,5 | 48,4 |
Short time liabilities | 34,1 | 43,2 | 50,8 | 17,5 |
Equity capital | -27,6 | -38 | -45,7 | -20,5 |
Operating profit (EBIT) | -12,1 | -8,9 | -4,8 | 46,1 |
Assets | 6,8 | 5,3 | 5,5 | 3,4 |
Net profit (loss) | -13,2 | -10,4 | -7,8 | 25 |
Cash | 0 | 0,1 | 0 | -93,8 |
Net income from sale | 41 | 56,2 | 49,7 | -11,7 |
Liabilities and provisions for liabilities | 34,4 | 43,3 | 51,3 | 18,4 |
Working assets | 6,2 | 3,7 | 3,6 | -3,1 |
Depreciation | 0,1 | 0,1 | 0,3 | 134,3 |
% | % | % | p.p. | |
Profitability of capital | 47,7 | 27,4 | 17 | -10,4 |
Equity capital to total assets | -404,5 | -712,9 | -830,9 | -118 |
Gross profit margin | -32,4 | -19,1 | -14,2 | 4,9 |
EBITDA Margin | -29,2 | -15,6 | -9,1 | 6,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 304 | 280 | 373 | 93 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane